A Pfizer-BioNTech COVID-19 vaccine booster in children ages 5-11 years significantly increased neutralizing antibody titers against the omicron variant with no new safety concerns, according to new data from the manufacturers. “These data reinforce the potential function of a third dose of the vaccine in maintaining high levels of protection against the virus in this…
Read More